Viewing Study NCT00001693

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:06 AM
Ignite Modification Date: 2026-06-26 @ 5:07 AM
Study NCT ID: NCT00001693
Status: COMPLETED
Last Update Posted: 2008-03-04
First Post: 1999-11-03
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Neoplasm View
None Hereditary Nonpolyposis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chemoprevention View
None Biomarkers View
None Endoscopy View
None Colorectal View
None Celecoxib View